Douglas Miehm
Stock Analyst at RBC Capital
(0.96)
# 2,756
Out of 4,412 analysts
30
Total ratings
38.1%
Success rate
-13.32%
Average return
Main Sectors:
3 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Maintains: Sector Perform | $12 → $11 | $8.71 | +26.29% | 15 | Apr 23, 2024 | |
| BLCO Bausch + Lomb | Maintains: Outperform | $20 → $18 | $14.79 | +21.70% | 7 | Apr 22, 2024 | |
| AUPH Aurinia Pharmaceuticals | Maintains: Outperform | $13 → $8 | $4.91 | +62.93% | 8 | Feb 16, 2024 |
Bausch Health Companies
Apr 23, 2024
Maintains: Sector Perform
Price Target: $12 → $11
Current: $8.71
Upside: +26.29%
Bausch + Lomb
Apr 22, 2024
Maintains: Outperform
Price Target: $20 → $18
Current: $14.79
Upside: +21.70%
Aurinia Pharmaceuticals
Feb 16, 2024
Maintains: Outperform
Price Target: $13 → $8
Current: $4.91
Upside: +62.93%